Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1993 Nov;53(5):973–986.

Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.

H S Scott 1, T Litjens 1, P V Nelson 1, P R Thompson 1, D A Brooks 1, J J Hopwood 1, C P Morris 1
PMCID: PMC1682315  PMID: 8213840

Abstract

Mucopolysaccharidosis type I (MPS-I) is an autosomal recessive genetic disease caused by a deficiency of the lysosomal glycosidase alpha-L-iduronidase. Hurler (severe), Scheie (mild), and Hurler/Scheie (intermediate) syndromes are clinical subtypes of MPS-I, but it is difficult to distinguish between these subtypes by biochemical measurements. Mutation analysis was undertaken to provide a molecular explanation for the clinical variation seen in MPS-I. Using chemical cleavage and direct PCR sequencing, we have defined four previously undescribed mutations for MPS-I (delG1702, 1060 + 2t-->c, R89Q, and 678-7g-->a). R89Q and 678-7g-->a were found to be present in 40% of Scheie syndrome alleles. Expression of R89Q demonstrated reduced stability and activity of the mutant protein. The deleterious effect of R89Q may be potentiated by a polymorphism (A361T) to produce an intermediate phenotype. 678-7g-->a was found to be a mild mutation, since it was present in an index Scheie syndrome patient in combination with a severe allele (W402X). This mutation appears to allow a very small amount of normal mRNA to be produced from the allele which is likely to be responsible for the mild clinical phenotype observed. Both the 5' and 3' splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations. The frameshift mutation (delG1702) and the 5' splice site mutation (1060 + 2t-->c) are both thought to be associated with severe MPS-I. The identification of these MPS-I mutations begins to document the expected genetic heterogeneity in MPS-I and provides the first molecular explanations for the broad range of clinical phenotypes observed.

Full text

PDF
973

Images in this article

979Figure 2
on p.979
980Figure 3
on p.980

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anson D. S., Taylor J. A., Bielicki J., Harper G. S., Peters C., Gibson G. J., Hopwood J. J. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J. 1992 Jun 15;284(Pt 3):789–794. doi: 10.1042/bj2840789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashton L. J., Brooks D. A., McCourt P. A., Muller V. J., Clements P. R., Hopwood J. J. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. Am J Hum Genet. 1992 Apr;50(4):787–794. [PMC free article] [PubMed] [Google Scholar]
  3. Bach G., Friedman R., Weissmann B., Neufeld E. F. The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidase. Proc Natl Acad Sci U S A. 1972 Aug;69(8):2048–2051. doi: 10.1073/pnas.69.8.2048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper D. N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988 Feb;78(2):151–155. doi: 10.1007/BF00278187. [DOI] [PubMed] [Google Scholar]
  5. Cullen B. R. Expression of a cloned human interleukin-2 cDNA is enhanced by the substitution of a heterologous mRNA leader region. DNA. 1988 Nov;7(9):645–650. doi: 10.1089/dna.1988.7.645. [DOI] [PubMed] [Google Scholar]
  6. Eisensmith R. C., Woo S. L. Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat. 1992;1(1):13–23. doi: 10.1002/humu.1380010104. [DOI] [PubMed] [Google Scholar]
  7. Glukhov A. I., Gordeev S. A., Vinogradov S. V., Kiselev V. I., Kramarov V. M., Kiselev O. I., Severin E. S. Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes. 1990 Dec;4(6):435–443. doi: 10.1016/0890-8508(90)90002-h. [DOI] [PubMed] [Google Scholar]
  8. Hedley M. L., Forman J., Tucker P. W. Mutation of 3' splice sites in two different class I genes results in different usage of cryptic splice sites. J Immunol. 1989 Aug 1;143(3):1018–1025. [PubMed] [Google Scholar]
  9. Hopwood J. J., Morris C. P. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med. 1990 Oct;7(5):381–404. [PubMed] [Google Scholar]
  10. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  11. McKusick V. A., Howell R. R., Hussels I. E., Neufeld E. F., Stevenson R. E. Allelism, non-allelism, and genetic compounds among the mucopolysaccharidoses. Lancet. 1972 May 6;1(7758):993–996. doi: 10.1016/s0140-6736(72)91159-2. [DOI] [PubMed] [Google Scholar]
  12. McKusick V. A., Kaplan D., Wise D., Hanley W. B., Suddarth S. B., Sevick M. E., Maumanee A. E. The genetic mucopolysaccharidoses. Medicine (Baltimore) 1965 Nov;44(6):445–483. doi: 10.1097/00005792-196511000-00001. [DOI] [PubMed] [Google Scholar]
  13. Muller V. J., Hopwood J. J. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate. Clin Genet. 1984 Nov;26(5):414–421. doi: 10.1111/j.1399-0004.1984.tb01081.x. [DOI] [PubMed] [Google Scholar]
  14. Nelson C., Rabb H., Arnaout M. A. Genetic cause of leukocyte adhesion molecule deficiency. Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta 2 integrins. J Biol Chem. 1992 Feb 15;267(5):3351–3357. [PubMed] [Google Scholar]
  15. Neufeld E. F. Lysosomal storage diseases. Annu Rev Biochem. 1991;60:257–280. doi: 10.1146/annurev.bi.60.070191.001353. [DOI] [PubMed] [Google Scholar]
  16. Patterson D., Berger R., Bleskan J., Vannais D., Davidson J. A single base change at a splice acceptor site leads to a truncated CAD protein in Urd-A mutant Chinese hamster ovary cells. Somat Cell Mol Genet. 1992 Jan;18(1):65–75. doi: 10.1007/BF01233449. [DOI] [PubMed] [Google Scholar]
  17. Robberson B. L., Cote G. J., Berget S. M. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol. 1990 Jan;10(1):84–94. doi: 10.1128/mcb.10.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rossi A. M., Thijssen J. C., Tates A. D., Vrieling H., Natarajan A. T., Lohman P. H., van Zeeland A. A. Mutations affecting RNA splicing in man are detected more frequently in somatic than in germ cells. Mutat Res. 1990 Aug;244(4):353–357. doi: 10.1016/0165-7992(90)90084-w. [DOI] [PubMed] [Google Scholar]
  19. SCHEIE H. G., HAMBRICK G. W., Jr, BARNESS L. A. A newly recognized forme fruste of Hurler's disease (gargoylism). Am J Ophthalmol. 1962 May;53:753–769. [PubMed] [Google Scholar]
  20. Sakuraba H., Eng C. M., Desnick R. J., Bishop D. F. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease. Genomics. 1992 Apr;12(4):643–650. doi: 10.1016/0888-7543(92)90288-4. [DOI] [PubMed] [Google Scholar]
  21. Scott H. S., Anson D. S., Orsborn A. M., Nelson P. V., Clements P. R., Morris C. P., Hopwood J. J. Human alpha-L-iduronidase: cDNA isolation and expression. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9695–9699. doi: 10.1073/pnas.88.21.9695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Scott H. S., Guo X. H., Hopwood J. J., Morris C. P. Structure and sequence of the human alpha-L-iduronidase gene. Genomics. 1992 Aug;13(4):1311–1313. doi: 10.1016/0888-7543(92)90053-u. [DOI] [PubMed] [Google Scholar]
  23. Scott H. S., Litjens T., Hopwood J. J., Morris C. P. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. Hum Mutat. 1992;1(2):103–108. doi: 10.1002/humu.1380010204. [DOI] [PubMed] [Google Scholar]
  24. Scott H. S., Nelson P. V., Hopwood J. J., Morris C. P. PCR of a KpnI RFLP in the alpha-L-iduronidase (IDUA) gene. Nucleic Acids Res. 1991 Oct 25;19(20):5796–5796. doi: 10.1093/nar/19.20.5796-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Steingrimsdottir H., Rowley G., Dorado G., Cole J., Lehmann A. R. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res. 1992 Mar 25;20(6):1201–1208. doi: 10.1093/nar/20.6.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Talerico M., Berget S. M. Effect of 5' splice site mutations on splicing of the preceding intron. Mol Cell Biol. 1990 Dec;10(12):6299–6305. doi: 10.1128/mcb.10.12.6299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weil D., Bernard M., Combates N., Wirtz M. K., Hollister D. W., Steinmann B., Ramirez F. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. J Biol Chem. 1988 Jun 25;263(18):8561–8564. [PubMed] [Google Scholar]
  28. Wiesmann U., Neufeld E. F. Scheie and Hurler syndromes: apparent identity of the biochemical defect. Science. 1970 Jul 3;169(3940):72–74. doi: 10.1126/science.169.3940.72. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES